Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.South Korea's investigation department: The civil unrest emissary can be arrested urgently. On the morning of December 11th, local time, Wu Dongyun, director of the Crime Investigation Department of South Korea's senior public officials, said in an inquiry about the state of "emergency martial law" in the South Korean National Assembly that according to Korean law, the civil unrest emissary can be arrested urgently. On the same day, the South Korean police seized and searched the South Korean Presidential Palace in Longshan District, Seoul. (CCTV News)Adani Port Company withdrew its loan request of US$ 553 million from the United States. On December 10th, local time, Adani Port Company stated that it would provide funds for its Colombo Port Terminal Project through internal accrual project and capital management plan, and withdrew its request for funds from DFC. DFC said last year that it would provide $553 million in financing for the port terminal project, which is partly owned by Adani Group. Last month, gautam Adani, the chairman of Adani Group, and seven other men were charged in the federal court in new york on suspicion of large-scale bribery and fraudulent schemes.
As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.The Taiwan Affairs Office of the State Council introduced the annual meeting of the 2024 Cross-Strait Entrepreneur Summit. Zhu Fenglian, a spokesperson for the Taiwan Affairs Office, said that the 2024 Cross-Strait Entrepreneur Summit was successfully held in Xiamen, Fujian from December 9 to 10. More than 700 business people from both sides of the Taiwan Strait attended the annual summit. Focusing on the theme of "Building a new era industrial chain across the Taiwan Strait to promote cross-strait economic integration and development", they conducted in-depth discussions on issues such as promoting cross-strait industrial Internet innovation, building Taiwanese enterprises to land in their first homes, and innovating cross-strait financial service systems. The exchange atmosphere was warm, which fully demonstrated the common aspiration of cross-strait industries to strengthen exchanges and cooperation. (Riyue Tan Tian)AKIRA AMARI, a former Japanese parliamentarian, said that relying on TSMC alone for high-end chips is the biggest risk.
How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Musk praised Tesla China. According to the data, Tesla sold 21,900 vehicles in China last week (12.2-12.8), which was the second best week of Tesla in 2024 so far. The excellent sales performance in China market was highly recognized by Tesla CEO Musk, who praised "the excellent work of Tesla China" online on social media.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide